Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06575751 · ClinicalTrials.gov registry record · Phase 2

Cannabidiol and Cannabis Concentrate Users

A Phase 2 study of Cannabis Use Disorder, sponsored by University of Colorado, Denver.

Recruiting
Registry status
Phase 2
Development phase
120
Enrollment target
1
Study location

NCT06575751 is a Phase 2 study of Cannabis Use Disorder that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, above the 106-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06575751, a Phase 2 study of Cannabis Use Disorder, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, placebo-controlled, dose-ranging trial of plant-derived cannabidiol (CBD) among people who regularly use cannabis concentrates but are not trying to stop or cut down on their use. The main questions it aims to answer are whether CBD, relative to placebo, reduces cannabis concentrate use, the subjective effects of cannabis, or cannabis craving. Participants will take CBD (200 mg or 400 mg per day) or placebo for 4 weeks and will complete three visits during the study medication period, all conducted using a mobile laboratory.

Conditions Studied

Cannabis Use Disorder

Interventions

  • DRUG Placebo
  • DRUG Broad Spectrum Cannabidiol (bsCBD) 400 mg
  • DRUG Broad Spectrum Cannabidiol (bsCBD) 200 mg

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-12-04
Est. Completion 2028-06-30
Phase Phase 2

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06575751

The ClinicalTrials.gov registry entry for NCT06575751 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 106-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (13% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06575751 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06575751 about?

NCT06575751 is a clinical study titled "Cannabidiol and Cannabis Concentrate Users". This study is a randomized, placebo-controlled, dose-ranging trial of plant-derived cannabidiol (CBD) among people who regularly use cannabis concentrates but are not trying to stop or cut down on their use. The main questions it aims to answer are whether CBD, relative to placebo, reduces cannabis ...

What is the current status of trial NCT06575751?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2024-12-04. Estimated completion is 2028-06-30.

What conditions does trial NCT06575751 study?

This clinical trial studies the following conditions: Cannabis Use Disorder.

What interventions are being tested in trial NCT06575751?

The interventions under investigation include: Placebo (DRUG), Broad Spectrum Cannabidiol (bsCBD) 400 mg (DRUG), Broad Spectrum Cannabidiol (bsCBD) 200 mg (DRUG).

Who is sponsoring clinical trial NCT06575751?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06575751 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cannabis Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cannabis Use Disorder

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.